Sacramento, CA27 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Sacramento, CA

Find 27 actively recruiting myalgic encephalomyelitis clinical trials in Sacramento, CA. Connect with local research sites and explore new treatment options.

27
Active Trials
18
Sponsors
10,625
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Sacramento

About Myalgic Encephalomyelitis Clinical Trials in Sacramento

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 27 myalgic encephalomyelitis clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 10,625 participants. Research is being sponsored by AstraZeneca, Alliance for Clinical Trials in Oncology, Direct Biologics, LLC and 15 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Sacramento — FAQ

Are there myalgic encephalomyelitis clinical trials in Sacramento?

Yes, there are 27 myalgic encephalomyelitis clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 27 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov